| 000 | 01537 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514015811.0 | ||
| 264 | 0 | _c20020517 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0277-0008 | ||
| 024 | 7 |
_a10.1592/phco.21.11.1010.34517 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuter, D J | |
| 245 | 0 | 0 |
_aHematologic effects of antimicrobials: focus on the oxazolidinone linezolid. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cAug 2001 |
||
| 300 |
_a1010-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnemia _xchemically induced |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHematologic Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aOxazolidinones _xadministration & dosage |
| 650 | 0 | 4 | _aPolypharmacy |
| 650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aTillotson, G S | |
| 773 | 0 |
_tPharmacotherapy _gvol. 21 _gno. 8 _gp. 1010-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.21.11.1010.34517 _zAvailable from publisher's website |
| 999 |
_c11632976 _d11632976 |
||